These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16277895)

  • 1. [Study of the prevention of chemotherapy-induced ovarian damage by gonadotropin-releasing hormone agonist in rat model].
    Yuan GW; Shen K; Yang JX
    Zhonghua Fu Chan Ke Za Zhi; 2005 Oct; 40(10):666-9. PubMed ID: 16277895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of gonadotropin releasing hormone analogues on chemotherapy-induced ovarian function damage in rats].
    Peng P; Yang DZ; Zheng CY; Mo YQ; He YM; Zhang QX
    Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):546-50. PubMed ID: 17983495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Protective effect of estrogen against chemotherapy-induced ovarian damage in rats].
    Han LP; He YL
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 May; 29(5):872-5. PubMed ID: 19460696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influence of gonadotropin-releasing hormone agonist on the effects of chemotherapy upon ovarian cancer: an experimental study with rat model].
    Yuan GW; Shen K; Yang JX
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(20):1428-31. PubMed ID: 16029659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of GnRH analogs on the expression of Bcl-2 gene family in the ovary of rats with cyclophosphamide-induced ovarian damage].
    Peng P; Yang DZ; Yang CH; Zhang W; Zhang YL; Liu J; Ye CL
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Nov; 28(11):2014-7. PubMed ID: 19033116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A luteinizing hormone-releasing hormone agonist for the prevention of chemotherapy-induced ovarian follicular loss in rats.
    Ataya KM; McKanna JA; Weintraub AM; Clark MR; LeMaire WJ
    Cancer Res; 1985 Aug; 45(8):3651-6. PubMed ID: 3926307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of a GnRH agonist with an antagonist prevents flare-up effects and protects primordial ovarian follicles in the rat ovary from cisplatin-induced toxicity: a controlled experimental animal study.
    Li X; Kang X; Deng Q; Cai J; Wang Z
    Reprod Biol Endocrinol; 2013 Mar; 11():16. PubMed ID: 23452939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of gonadotropin-releasing hormone (GnRH) receptor-I expression in the pituitary and ovary by a GnRH agonist and antagonist.
    Mo Y; Peng P; Zhou R; He Z; Huang L; Yang D
    Reprod Sci; 2010 Jan; 17(1):68-77. PubMed ID: 19861704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The GnRH antagonist reduces chemotherapy-induced ovarian damage in rats by suppressing the apoptosis.
    Huang YH; Zhao XJ; Zhang QH; Xin XY
    Gynecol Oncol; 2009 Feb; 112(2):409-14. PubMed ID: 19038435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of gonadotroph-releasing hormone analogues on follicle apoptosis in rats with chemotherapy-induced ovarian damage].
    Peng P; Mo YQ; Yang CH; Zhang W; Zhang YL; Liu J; Ye CL; Yang DZ
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jan; 30(1):106-10. PubMed ID: 20117996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GnRH analogs do not protect ovaries from chemotherapy-induced ultrastructural injury in Hodgkin's lymphoma patients.
    Nitzschke M; Raddatz J; Bohlmann MK; Stute P; Strowitzki T; von Wolff M
    Arch Gynecol Obstet; 2010 Jul; 282(1):83-8. PubMed ID: 19967405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lentivirus-mediated bcl-2 gene therapy improves function and structure of chemotherapy-damaged ovaries in wistar rats.
    Wang X; He Y; Liu M; Fu X
    Am J Reprod Immunol; 2013 May; 69(5):518-28. PubMed ID: 23311825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of gonadotropin-releasing hormone analog on the ovarian reserve in rats receiving cyclophosphamide treatment.
    Gui T; Yuan G; Shen K; Cao D; Yang J; Wu M; Lang J
    Onco Targets Ther; 2015; 8():661-7. PubMed ID: 25848306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of gonadotropin releasing hormone analogues for ovarian protection in systemic lupus erythematosus patients treated with cyclophosphamide].
    Liang LQ; Qiu Q; Yang XY; Xu HS; Ye YJ; Zhan ZP; Lian F; Chen DY
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(15):1009-11. PubMed ID: 18754430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of ionizing radiation and pretreatment with [D-Leu6,des-Gly10] luteinizing hormone-releasing hormone ethylamide on developing rat ovarian follicles.
    Jarrell J; YoungLai EV; McMahon A; Barr R; O'Connell G; Belbeck L
    Cancer Res; 1987 Oct; 47(19):5005-8. PubMed ID: 3113726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian toxicity of cyclophosphamide alone and in combination with ovarian irradiation in the rat.
    Jarrell J; Lai EV; Barr R; McMahon A; Belbeck L; O'Connell G
    Cancer Res; 1987 May; 47(9):2340-3. PubMed ID: 3105875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer.
    Doldi N; Persico P; Di Sebastiano F; Marsiglio E; Ferrari A
    Gynecol Endocrinol; 2006 May; 22(5):235-8. PubMed ID: 16785142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer.
    Ku SY; Choi YS; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY; Kim SH
    Gynecol Endocrinol; 2005 Oct; 21(4):227-31. PubMed ID: 16316845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early postnatal methoxychlor exposure inhibits folliculogenesis and stimulates anti-Mullerian hormone production in the rat ovary.
    Uzumcu M; Kuhn PE; Marano JE; Armenti AE; Passantino L
    J Endocrinol; 2006 Dec; 191(3):549-58. PubMed ID: 17170213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anovulation in the prevention of cytotoxic-induced follicular attrition and ovarian failure.
    Letterie GS
    Hum Reprod; 2004 Apr; 19(4):831-7. PubMed ID: 15033951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.